PMVP · Categories · Form 4

PMVP - SEC Form 4 insider transactions

PMV Pharmaceuticals Inc. (PMVP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for PMVP

• 48d
  SEC Form 4 filed by Chief Financial Officer Carulli Michael

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 48d
  SEC Form 4 filed by General Counsel & COO Ticktin Robert

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 48d
  SEC Form 4 filed by Chief Development Officer Jalota Deepika

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 48d
  SEC Form 4 filed by President and CEO Mack David Henry

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 179d
  President and CEO Mack David Henry exercised 220,643 shares at a strike of $1.37, increasing direct ownership by 96% to 451,109 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 181d
  Large owner Orbimed Advisors Llc sold $1,520,000 worth of shares (1,000,000 units at $1.52) (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 226d
  Large owner Orbimed Advisors Llc sold $900,000 worth of shares (500,000 units at $1.80) (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 297d
  General Counsel & COO Ticktin Robert sold $24,651 worth of shares (23,151 units at $1.06), decreasing direct ownership by 19% to 98,695 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 297d
  Chief Development Officer Jalota Deepika sold $35,198 worth of shares (33,065 units at $1.06), decreasing direct ownership by 27% to 89,959 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 297d
  Chief Financial Officer Carulli Michael sold $30,077 worth of shares (28,249 units at $1.06), decreasing direct ownership by 32% to 60,146 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 297d
  President and CEO Mack David Henry sold $62,179 worth of shares (58,411 units at $1.06), decreasing direct ownership by 10% to 536,133 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 321d
  SEC Form 4 filed by Director Stelzer Laurie

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 321d
  SEC Form 4 filed by Director Levine Arnold J

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 321d
  SEC Form 4 filed by Director Heyman Richard A.

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 321d
  SEC Form 4 filed by Director Gallagher Carol Giltner

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 321d
  SEC Form 4 filed by Director Flowers Kirsten

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 321d
  SEC Form 4 filed by Director Baum Charles M

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 417d
  SEC Form 4 filed by Chief Financial Officer Carulli Michael

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 417d
  SEC Form 4 filed by Chief Development Officer Jalota Deepika

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 417d
  SEC Form 4 filed by President and CEO Mack David Henry

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 459d
  President and CEO Mack David Henry exercised 109,459 shares at a strike of $0.53, increasing direct ownership by 25% to 551,919 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 570d
  SEC Form 4 filed by Chief Development Officer Jalota Deepika

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 570d
  SEC Form 4 filed by Chief Financial Officer Carulli Michael

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 570d
  SEC Form 4 filed by President and CEO Mack David Henry

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 591d
  Chief Development Officer Jalota Deepika sold $10,853 worth of shares (7,218 units at $1.50), decreasing direct ownership by 6% to 118,283 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 591d
  Chief Financial Officer Carulli Michael sold $4,347 worth of shares (2,891 units at $1.50), decreasing direct ownership by 3% to 88,395 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 685d
  SEC Form 4 filed by Director Stelzer Laurie

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 685d
  SEC Form 4 filed by Director Levine Arnold J

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 685d
  SEC Form 4 filed by Director Heyman Richard A.

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 685d
  SEC Form 4 filed by Director Gallagher Carol Giltner

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 685d
  SEC Form 4 filed by Director Flowers Kirsten

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 685d
  SEC Form 4 filed by Director Baum Charles M

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 825d
  Jalota Deepika was granted 95,555 shares, increasing direct ownership by 319% to 125,501 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 825d
  Carulli Michael was granted 82,220 shares, increasing direct ownership by 907% to 91,286 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 825d
  Mack David Henry was granted 163,890 shares, increasing direct ownership by 59% to 442,460 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 884d
  Orbimed Advisors Llc sold $195,763 worth of shares (87,786 units at $2.23) (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 895d
  Mack David Henry exercised 198,407 shares at a strike of $0.53, gifted 85,307 shares and received a gift of 85,307 shares, increasing direct ownership by 68% to 278,570 units (SEC Form 4)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 951d
  SEC Form 4: Jalota Deepika sold $27,168 worth of shares (4,104 units at $6.62), decreasing direct ownership by 12% to 29,946 units

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 951d
  SEC Form 4: Alland Leila sold $41,646 worth of shares (6,291 units at $6.62), decreasing direct ownership by 12% to 45,909 units

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 992d
  SEC Form 4: Mack David Henry exercised 85,500 shares at a strike of $0.53, increasing direct ownership by 107% to 165,470 units

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1049d
  SEC Form 4 filed by Stelzer Laurie

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1049d
  SEC Form 4 filed by Levine Arnold J

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1049d
  SEC Form 4 filed by Heyman Richard A.

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1049d
  SEC Form 4 filed by Gallagher Carol Giltner

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1049d
  SEC Form 4 filed by Flowers Kirsten

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1049d
  SEC Form 4 filed by Baum Charles M

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1077d
  SEC Form 4 filed by Jalota Deepika

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1077d
  SEC Form 4 filed by Alland Leila

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1077d
  SEC Form 4 filed by Kung Winston

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1077d
  SEC Form 4 filed by Mack David Henry

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1182d
  SEC Form 4: Kung Winston gifted 2,560 shares, decreasing direct ownership by 19% to 10,600 units

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1265d
  SEC Form 4 filed by Gallagher Carol Giltner

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1321d
  SEC Form 4: Jalota Deepika was granted 34,050 shares

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1321d
  SEC Form 4: Alland Leila was granted 52,200 shares

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1420d
  SEC Form 4 filed by Stelzer Laurie

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1420d
  SEC Form 4 filed by Levine Arnold J

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1420d
  SEC Form 4 filed by Heyman Richard A.

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1420d
  SEC Form 4 filed by Flowers Kirsten

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1420d
  SEC Form 4 filed by Baum Charles M

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)
• 1426d
  SEC Form 4: Orbimed Advisors Llc sold $418,210 worth of shares (26,253 units at $15.93)

  4 - PMV Pharmaceuticals, Inc. (0001699382) (Issuer)

Other PMVP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends